Khurana V G, Feterik K, Springett M J, Eguchi D, Shah V, Katusic Z S
Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.
J Cereb Blood Flow Metab. 2000 Nov;20(11):1563-70. doi: 10.1097/00004647-200011000-00006.
Heat shock protein 90 (HSP90), an essential component of several signal transduction systems, participates in the activation of endothelial nitric oxide synthase (eNOS) in cells. The objective of the current study was to determine if HSP90 and eNOS were functionally interdependent and colocalized in the cerebral circulation. The authors used isometric force recording, cyclic 3'5'-guanosine monophosphate (cGMP) radioimmunoassay (RIA), and immunogold electron microscopy (EM) to study canine basilar artery. They found that geldanamycin (0.1 to 10 microg/mL), a selective HSP90 inhibitor, caused concentration-dependent contractions in arterial rings (n = 6 dogs). Contractions to geldanamycin were unaffected by a cyclooxygenase inhibitor, indomethacin (10 micromol/L; P < 0.05, n = 6). Functional evidence for interaction between HSP90 and nitric oxide (NO)-mediated signaling included observations that the contractile effect of geldanamycin was the following: (1) endothelium-dependent, (2) abolished by Ng-nitro-L-arginine methylester (L-NAME; 0.3 mmol/L), and (3) non-additive with the contractile effect of this NOS inhibitor (P < 0.01, n = 6 for each). Furthermore, RIA showed significant reduction in cGMP levels in arteries treated with geldanamycin (3 microg/mL; P < 0.02, n = 8), whereas immunogold EM demonstrated areas of colocalization of HSP90 and eNOS selectively in the cytoplasm of endothelial cells. The current findings suggest that in cerebral arteries, endothelial HSP90 plays an important role in modulation of basal NO-mediated signaling. This interaction may be particularly important in stress-induced up-regulation of HSP90 with subsequent alteration of vasomotor function.
热休克蛋白90(HSP90)是几种信号转导系统的重要组成部分,参与细胞内内皮型一氧化氮合酶(eNOS)的激活。本研究的目的是确定HSP90和eNOS在功能上是否相互依赖以及在脑循环中是否共定位。作者采用等长力记录、环磷酸鸟苷(cGMP)放射免疫分析(RIA)和免疫金电子显微镜(EM)技术研究犬基底动脉。他们发现,选择性HSP90抑制剂格尔德霉素(0.1至10微克/毫升)可引起动脉环浓度依赖性收缩(n = 6只犬)。格尔德霉素引起的收缩不受环氧合酶抑制剂吲哚美辛(10微摩尔/升)的影响(P < 0.05,n = 6)。HSP90与一氧化氮(NO)介导的信号传导之间相互作用的功能证据包括以下观察结果:格尔德霉素的收缩作用(1)依赖于内皮,(2)被N-硝基-L-精氨酸甲酯(L-NAME;0.3毫摩尔/升)消除,(3)与该一氧化氮合酶抑制剂的收缩作用无相加性(P < 0.01,每组n = 6)。此外,RIA显示,用格尔德霉素(3微克/毫升)处理的动脉中cGMP水平显著降低(P < 0.02,n = 8),而免疫金EM显示HSP90和eNOS选择性地在内皮细胞胞质中共定位区域。目前的研究结果表明,在脑动脉中,内皮HSP90在调节基础NO介导的信号传导中起重要作用。这种相互作用在应激诱导的HSP90上调以及随后血管舒缩功能改变中可能尤为重要。